Author

Amy E. Comander

Institution: Newton Wellesley Hospital

Observed institution: Newton Wellesley Hospital

OpenAlex ID: A5114043665

Abstract PD17-03: Cell-free DNA monitoring in a phase II study of adjuvant endocrine therapy with CDK 4/6 inhibitor ribociclib for localized HR+/HER2- breast cancer (LEADER)

2023 · Arielle J. Medford, Lauren Scarpetti, et al. · Cancer Research · 4

Works count: 1

Citation count: 4

H-index: 1

I10-index: